A venture arm of an international pharmaceutical company is committed to advancing healthcare innovation globally. The firm identifies, supports, and invests in transformative technologies that align with the parent company’s strategic vision of improving health and quality of life.
The firm seeks opportunities in therapeutics, diagnostics, digital health, and medical devices, with a particular emphasis on products and innovations that can expand the parent company’s Women’s Health portfolio. The organization is especially interested in solutions that improve the healthcare journey for women and address gaps in existing therapeutic and diagnostic options.
The firm is open to collaborations in addition to investments, including partnerships with companies whose products are already on the market and are looking to expand into new geographies. Leveraging the parent company’s extensive global network, the firm aims to help these companies access new markets and scale their impact.
The firm supports management teams with diverse expertise and a strong commitment to innovation. While a proven track record in the life sciences is advantageous, the firm is eager to collaborate with promising teams developing solutions aligned with the parent company’s strategic priorities. The venture is open to co-investment opportunities with partners who share its vision.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment